Product Information
TACROLIMUS 0.1% OINTMENT is a generic product labeled by Encube Ethicals, Inc., priced at $1.0423 per GM under NDC 21922001105. Its NADAC has been published 145 times since Feb 14, 2024.
FDA first approved this application on Oct 10, 2023. Its Orange Book therapeutic-equivalence code is BX.
Strength
1 mg/g
Manufacturer
Encube Ethicals, Inc.NDC
21922001105
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
11/18/2026
Active Ingredients
TACROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA212387FDA Approved
10/10/2023
TE Code
BX
On Market Since
10/13/2023
Pharmacological Classes
Price Statistics
The NADAC for TACROLIMUS 0.1% OINTMENT has been published 145 times since Feb 14, 2024, and over the history we have for it it has declined 16.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0423 per GM |
|---|---|
| All-time high | $1.3572 (Apr 10, 2024) |
| All-time low | $0.7143 (Nov 20, 2024) |
| 52-week high | $1.0423 |
| 52-week low | $0.9245 |
| Median price | $0.9839 |
| Average price | $1.0102 |
| Largest weekly change | +41.4% (Aug 21, 2024) |
| Weeks tracked | 145 |
| Tracking since | Feb 14, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Encube Ethicals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tacrolimus Ointment 0.1% market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcineurin Inhibitor Immunosuppressant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TACROLIMUS 0.1% OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for TACROLIMUS 0.1% OINTMENT, manufactured by Encube Ethicals, Inc., is $1.0423 per GM (NDC 21922001105), effective Nov 18, 2026.
How has the price of TACROLIMUS 0.1% OINTMENT changed over time?
Over the history we have for it, the NADAC for TACROLIMUS 0.1% OINTMENT has declined 16.3%. It has been tracked across 145 weekly CMS publications since Feb 14, 2024.
What are the highest and lowest recorded NADAC prices for TACROLIMUS 0.1% OINTMENT?
Since Feb 14, 2024, the NADAC for TACROLIMUS 0.1% OINTMENT has ranged from a low of $0.7143 (Nov 20, 2024) to a high of $1.3572 (Apr 10, 2024), with a median of $0.9839 per GM.
Are there cheaper alternatives to TACROLIMUS 0.1% OINTMENT?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TACROLIMUS 0.1% OINTMENT in a comparable dosage form, but none are currently priced below it.
Who manufactures TACROLIMUS 0.1% OINTMENT?
TACROLIMUS 0.1% OINTMENT (NDC 21922001105) is labeled by Encube Ethicals, Inc., and CMS classifies it as a generic product.